← Companies|Proteus Digital
Pr

Proteus Digital

Redwood City CAFounded 2001300 employees
Private CapbiotechAcquiredMetabolic
Platform: Digital Pill
Market Cap
N/A
All Drugs
3
Clinical Trials
6
Failed / Terminated
2
FDA Approved
1
Drug Pipeline (3 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
IvotapinarofPRO-4672Approved4PeptideFGFRKIF18AiLN
PRO-7290PRO-7290Phase 2/31VaccineB7-H3Anti-TauOvarian CaFabry
DoxazanubrutinibPRO-5650Phase 31RadioligandMALT1Anti-TauFabryRCC
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (4)
2025-09-08
Ivotapinarof Ph3 Readout
LN
Past
2026-04-18
PRO-7290 Ph3 Readout
Ovarian Ca
Ph3 Readout
2028-09-26
Doxazanubrutinib Ph3 Readout
PV
Ph3 Readout
2031-12-04
Ivotapinarof Ph3 Readout
LN
Ph3 Readout